Literature DB >> 21717479

DockoMatic: automated peptide analog creation for high throughput virtual screening.

Reed B Jacob1, Casey W Bullock, Tim Andersen, Owen M McDougal.   

Abstract

The purpose of this manuscript is threefold: (1) to describe an update to DockoMatic that allows the user to generate cyclic peptide analog structure files based on protein database (pdb) files, (2) to test the accuracy of the peptide analog structure generation utility, and (3) to evaluate the high throughput capacity of DockoMatic. The DockoMatic graphical user interface interfaces with the software program Treepack to create user defined peptide analogs. To validate this approach, DockoMatic produced cyclic peptide analogs were tested for three-dimensional structure consistency and binding affinity against four experimentally determined peptide structure files available in the Research Collaboratory for Structural Bioinformatics database. The peptides used to evaluate this new functionality were alpha-conotoxins ImI, PnIA, and their published analogs. Peptide analogs were generated by DockoMatic and tested for their ability to bind to X-ray crystal structure models of the acetylcholine binding protein originating from Aplysia californica. The results, consisting of more than 300 simulations, demonstrate that DockoMatic predicts the binding energy of peptide structures to within 3.5 kcal mol(-1), and the orientation of bound ligand compares to within 1.8 Å root mean square deviation for ligand structures as compared to experimental data. Evaluation of high throughput virtual screening capacity demonstrated that Dockomatic can collect, evaluate, and summarize the output of 10,000 AutoDock jobs in less than 2 hours of computational time, while 100,000 jobs requires approximately 15 hours and 1,000,000 jobs is estimated to take up to a week.
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21717479      PMCID: PMC3142323          DOI: 10.1002/jcc.21864

Source DB:  PubMed          Journal:  J Comput Chem        ISSN: 0192-8651            Impact factor:   3.376


  10 in total

Review 1.  Computational approaches to understand alpha-conotoxin interactions at neuronal nicotinic receptors.

Authors:  Sébastien Dutertre; Richard J Lewis
Journal:  Eur J Biochem       Date:  2004-06

Review 2.  Structure-activity relationships of alpha-conotoxins targeting neuronal nicotinic acetylcholine receptors.

Authors:  Emma L Millard; Norelle L Daly; David J Craik
Journal:  Eur J Biochem       Date:  2004-06

Review 3.  Protein-ligand docking: current status and future challenges.

Authors:  Sérgio Filipe Sousa; Pedro Alexandrino Fernandes; Maria João Ramos
Journal:  Proteins       Date:  2006-10-01

4.  Toxin insights into nicotinic acetylcholine receptors.

Authors:  Sébastien Dutertre; Richard J Lewis
Journal:  Biochem Pharmacol       Date:  2006-04-22       Impact factor: 5.858

5.  VMD: visual molecular dynamics.

Authors:  W Humphrey; A Dalke; K Schulten
Journal:  J Mol Graph       Date:  1996-02

6.  alpha-Conotoxins selectively inhibit one of the two acetylcholine binding sites of nicotinic receptors.

Authors:  D R Groebe; J M Dumm; E S Levitan; S N Abramson
Journal:  Mol Pharmacol       Date:  1995-07       Impact factor: 4.436

7.  Comparative protein modelling by satisfaction of spatial restraints.

Authors:  A Sali; T L Blundell
Journal:  J Mol Biol       Date:  1993-12-05       Impact factor: 5.469

8.  Dockomatic - automated ligand creation and docking.

Authors:  Casey W Bullock; Reed B Jacob; Owen M McDougal; Greg Hampikian; Tim Andersen
Journal:  BMC Res Notes       Date:  2010-11-08

9.  AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility.

Authors:  Garrett M Morris; Ruth Huey; William Lindstrom; Michel F Sanner; Richard K Belew; David S Goodsell; Arthur J Olson
Journal:  J Comput Chem       Date:  2009-12       Impact factor: 3.376

10.  Analogs of alpha-conotoxin MII are selective for alpha6-containing nicotinic acetylcholine receptors.

Authors:  J Michael McIntosh; Layla Azam; Sarah Staheli; Cheryl Dowell; Jon M Lindstrom; Alexander Kuryatov; James E Garrett; Michael J Marks; Paul Whiteaker
Journal:  Mol Pharmacol       Date:  2004-04       Impact factor: 4.436

  10 in total
  7 in total

1.  DockoMatic 2.0: high throughput inverse virtual screening and homology modeling.

Authors:  Casey Bullock; Nic Cornia; Reed Jacob; Andrew Remm; Thomas Peavey; Ken Weekes; Chris Mallory; Julia T Oxford; Owen M McDougal; Timothy L Andersen
Journal:  J Chem Inf Model       Date:  2013-08-08       Impact factor: 4.956

2.  Computational exploration of a protein receptor binding space with student proposed peptide ligands.

Authors:  Matthew D King; Paul Phillips; Matthew W Turner; Michael Katz; Sarah Lew; Sarah Bradburn; Tim Andersen; Owen M McDougal
Journal:  Biochem Mol Biol Educ       Date:  2015-11-05       Impact factor: 1.160

3.  Homology modeling and molecular docking for the science curriculum.

Authors:  Owen M McDougal; Nic Cornia; S V Sambasivarao; Andrew Remm; Chris Mallory; Julia Thom Oxford; C Mark Maupin; Tim Andersen
Journal:  Biochem Mol Biol Educ       Date:  2013-12-20       Impact factor: 1.160

4.  Accessible high-throughput virtual screening molecular docking software for students and educators.

Authors:  Reed B Jacob; Tim Andersen; Owen M McDougal
Journal:  PLoS Comput Biol       Date:  2012-05-31       Impact factor: 4.475

5.  SPIDR: small-molecule peptide-influenced drug repurposing.

Authors:  Matthew D King; Thomas Long; Daniel L Pfalmer; Timothy L Andersen; Owen M McDougal
Journal:  BMC Bioinformatics       Date:  2018-04-16       Impact factor: 3.169

6.  Qualitative Assay to Detect Dopamine Release by Ligand Action on Nicotinic Acetylcholine Receptors.

Authors:  Leanna A Marquart; Matthew W Turner; Owen M McDougal
Journal:  Toxins (Basel)       Date:  2019-11-20       Impact factor: 4.546

7.  Ribbon α-Conotoxin KTM Exhibits Potent Inhibition of Nicotinic Acetylcholine Receptors.

Authors:  Leanna A Marquart; Matthew W Turner; Lisa R Warner; Matthew D King; James R Groome; Owen M McDougal
Journal:  Mar Drugs       Date:  2019-11-28       Impact factor: 5.118

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.